TAS Medical

Executive Summary

TAS Medical is a private San Diego-based medical device company founded in 2015, focused on developing the Tissue Approximation System (TAS), a novel ZipStrap-based device for soft tissue closure in open, laparoscopic, and robotic surgeries. The device targets abdominal wall closure and hernia repair, addressing a significant unmet need for secure, efficient tissue approximation. While the company remains in early commercial stages with no disclosed funding or revenue, its innovative approach and experienced team position it well in the growing surgical closure market. The TAS system has the potential to reduce operative time and complications compared to traditional sutures, offering a compelling value proposition for surgeons and hospitals. However, as a private entity with limited public information, the company's trajectory depends on successful regulatory clearance and clinical adoption.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for TAS system70% success
• Q1 2027First-in-human clinical study results60% success
• Q4 2026Strategic partnership with a major medtech company50% success